GALIPDIA study: Reaching lipid targets in a population with type 2 diabetes (T2DM) from the Northwest of Spain Rocío Villar-Taibo; Eva Fernández-Rodríguez; Cristina Tejera-Pérez; Carmen Díaz-Ortega; Paula Sánchez-Sobrino; Regina Palmeiro-Carballeira; Nazareth Rodríguez-Novo; Gemma Rodríguez-Carnero; Iria Pinal-Osorio; Laura Cotovad-Bellas; Olaia Díaz-Trastoy; Beatriz Mantiñán-Gil; Paula Álvarez-Castro; Paula Andújar Plata; Inés Seoane-Cruz; Alma Prieto-Tenreiro; Rosa Argüeso Armesto; Antía Fernández-Pombo; Ana Sánchez-Bao; Alfonso Vidal-Casariego;

Interpretation of clinical trials on the cardiovascular effects of hypoglycemic drugs in people with type 2 diabetes Ana Romero; Gemma Llauradó; José-Miguel González-Clemente;

Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society Juan Pedro-Botet; Francisco Arrieta; Manuel Botana; José A. Gimeno-Orna; José I. Martínez-Montoro; Emilio Ortega-Martínez de Victoria; Josep Ribalta; Víctor Sánchez-Margalet; Antonio Pérez-Pérez;